Financials

BIOSGN fundamentals

An in-depth look to BIOSERGEN AB operating, investing, and financing activities

BIOSGN free cash flow for Q1 25 is -5.85 M SEK. For 2024, BIOSGN free cash flow was -10.18 M SEK and operating cash flow was -10.18 M SEK.

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: SEK